Ledger.Open graph →
SEC Form D · Amendment · filed December 23, 2025

Auron Therapeutics, Inc

Offering
$42.3M
Sold
$27.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David A. Wilson · London, United KingdomDirectorMatthew S. Cooper · Aspen, CODirectorWilliam U. Martin · Ann Arbor, MIExec · DirectorRobert C. Wynne · Zionsville, INDirectorE. Smith · Baltimore, MDDirectorEdward Hansen · Camden, MEDirectorPini D. Orbach · Newton, MADirectorPini D. Orbach · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗